Accelerate the next wave of antibody and protein innovation
Antibody and Protein R&D Solutions
Hundreds of biopharma innovators trust Benchling’s Antibody and Protein Solutions to advance their biologics through the R&D lifecycle. Work across a broad range of antibody and protein discovery modalities (e.g. phage display, hybridoma, B-cell) with fit-for-purpose software designed for speed, collaboration, and insights. Get the best from in silico molecular biology tools, ELN, LIMS, and LES in one modern, digital platform designed for biologics R&D.
The Antibody and Protein Therapy R&D Accelerators provide best practices that shorten time-to-value for research and process development. The Accelerators contain:
Data model – entity relationship diagram (ERD) which serves as an implementation blueprint
Tenant configuration – pre-defined tenant configuration using templates and dashboards for registering entities, tracking results, increasing inventory utilization, and streamlining workflows
Solution Guide – highlight capabilities and latest product features
Benchling’s services support customers from implementation through ongoing success.
Professional Services – solution-specific domain expertise to jumpstart your optimal implementation
Customer Success – continual solution optimization that takes advantage of new feature releases and ongoing industry learning
How we deliver
Dedicated expertise
Our Customer Experience professionals possess deep scientific expertise, as well as training on information technology best practices. They apply this know-how to support antibody customers across a wide range of R&D teams.
Continuous oversight
Leverage Benchling's pre-implementation solutions consulting, professional implementation services, and customer success management expertise to help you get the most out of Benchling.
Focused R&D support
Take advantage of Benchling’s foundational implementation guides, developed by our Customer Experience team to support many antibody R&D functions.
See Benchling's Antibody and Protein R&D Solution in action
Powering breakthroughs for over 1,200 biotechnology companies, from startups to Fortune 500s